119 related articles for article (PubMed ID: 25072284)
1. Type I Interferon Receptor Expression in Human Pancreatic and Periampullary Cancer Tissue.
Booy S; Hofland LJ; Waaijers AM; Croze E; van Koetsveld PM; de Vogel L; Biermann K; van Eijck CH
Pancreas; 2015 Jan; 44(1):99-105. PubMed ID: 25072284
[TBL] [Abstract][Full Text] [Related]
2. Differential expression and prognostic value of HMGA1 in pancreatic head and periampullary cancer.
van der Zee JA; ten Hagen TL; Hop WC; van Dekken H; Dicheva BM; Seynhaeve AL; Koning GA; Eggermont AM; van Eijck CH
Eur J Cancer; 2010 Dec; 46(18):3393-9. PubMed ID: 20724141
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Stratification and Long-term Follow-up of Patients with Periampullary Carcinomas.
Schmuck RB; Brokat C; Andreou A; Felsenstein M; Klein F; Sinn B; Pratschke J; Bahra M
Anticancer Res; 2018 Sep; 38(9):5379-5386. PubMed ID: 30194192
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic significance of thymidylate synthase (TS) in pancreatic head and periampullary cancer.
van der Zee JA; van Eijck CH; Hop WC; van Dekken H; Dicheva BM; Seynhaeve AL; Koning GA; Eggermont AM; Ten Hagen TL
Eur J Surg Oncol; 2012 Nov; 38(11):1058-64. PubMed ID: 22633450
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of epidermal growth factor receptor and insulin-like growth factor receptor 1 in patients with ampullary adenocarcinoma.
Xia M; Overman MJ; Rashid A; Chatterjee D; Wang H; Katz MH; Fleming JB; Lee JE; Varadhachary GR; Wolff RA; Wang H
Hum Pathol; 2015 Sep; 46(9):1315-22. PubMed ID: 26165226
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891.
Smeenk HG; van Eijck CH; Hop WC; Erdmann J; Tran KC; Debois M; van Cutsem E; van Dekken H; Klinkenbijl JH; Jeekel J
Ann Surg; 2007 Nov; 246(5):734-40. PubMed ID: 17968163
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker.
Chong Y; Thakur N; Paik KY; Lee EJ; Kang CS
BMC Cancer; 2020 Mar; 20(1):216. PubMed ID: 32171280
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of prognosis-associated factors in pancreatic head and peri-ampullary cancer].
Roder JD; Siewert JR
Chirurg; 1992 May; 63(5):410-5. PubMed ID: 1376655
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival after resection for non-pancreatic periampullary cancer followed by adjuvant intra-arterial chemotherapy and concomitant radiotherapy.
Erdmann JI; Morak MJ; Duivenvoorden HJ; van Dekken H; Kazemier G; Kok NF; van Eijck CH
HPB (Oxford); 2015 Jul; 17(7):573-9. PubMed ID: 25800041
[TBL] [Abstract][Full Text] [Related]
12. Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.
Buanes TA
World J Gastroenterol; 2016 Dec; 22(48):10502-10511. PubMed ID: 28082802
[TBL] [Abstract][Full Text] [Related]
13. Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.
Kwon MJ; Kim JW; Jung JP; Cho JW; Nam ES; Cho SJ; Kim JS; Park HR; Min SK; Seo J; Min KW; Kim DH; Jeon JY
Hum Pathol; 2016 Apr; 50():90-100. PubMed ID: 26997442
[TBL] [Abstract][Full Text] [Related]
14. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
[TBL] [Abstract][Full Text] [Related]
15. [Surgical therapy of pancreatic and periampullary carcinoma in elderly patients].
Benhidjeb T; Zanow J
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():489-91. PubMed ID: 9101908
[TBL] [Abstract][Full Text] [Related]
16. DNA analysis of periampullary cancers.
Katagiri H; Okayasu I; Endo M
Bull Tokyo Med Dent Univ; 1990 Jun; 37(1-2):1-18. PubMed ID: 2225281
[TBL] [Abstract][Full Text] [Related]
17. [Results of pancreaticoduodenectomy in the treatment of periampullary tumors].
Norero E; Viñuela E; Báez S; Martínez C; Reyes J; Kusanovic R; Sanhueza M; Aguayo G; Calvo A; Mege RM; Caracci M; Díaz A
Rev Med Chil; 2011 Aug; 139(8):1015-24. PubMed ID: 22215331
[TBL] [Abstract][Full Text] [Related]
18. Impact of lymph node ratio on survival in patients with pancreatic and periampullary cancer.
Tol JA; Brosens LA; van Dieren S; van Gulik TM; Busch OR; Besselink MG; Gouma DJ
Br J Surg; 2015 Feb; 102(3):237-45. PubMed ID: 25529117
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Excision Repair Cross-Complementing Gene 1, Dihydropyrimidine Dehydrogenase, and Human Equilibrative Nucleotide Transporter 1 Expression and Their Implications for Adjuvant Treatment in Patients With Ampullary Carcinoma.
Kawabata Y; Nishi T; Kidani A; Tajima Y
Pancreas; 2015 Aug; 44(6):937-44. PubMed ID: 25906447
[TBL] [Abstract][Full Text] [Related]
20. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]